National Kidney Foundation - Spring Clinical Meetings

 

9-13 de abril, Boston, Estados Unidos

 

 

Immunoglobulin A nephropathy (IgAN)

AFFINITY Study: 1y results of atrasentan in IgAN in patients with UPCR <1 and ≤1g/g

A mechanistic biopsy study to evaluate structural and functional changes in kidney of patients with IgA neophropathy (IgAN) receiving Iptacopan on top of supportive care

IgA Nephropathy (IgAN) & Complement 3 glomerulopathy (C3G)

 

 

Design of A Patiente (pt) Platform for Real-World Data (RWD) on Iptacopan and/or Atrasentan in the United States (APPRISE) for Pts With Immunoglobulin A Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G)

Design of a disease-management app to measure home-reported outcomes (HROs) in patients (pts) with IgA neohropathy (IgAN) and C3 glomerulopathy (C3G)